Greenland-Bews, Caitlin
Byrne, Rachel L.
Owen, Sophie I.
Watkins, Rachel L.
Bengey, Daisy
Buist, Kate
Clerkin, Karina
Escadafal, Camille
Finch, Lorna S.
Gould, Susan
Giorgi, Emanuele
Hodgkinson, Andy
Mashenko, Larysa
Powell, Darren
Savage, Helen R.
Thompson, Caitlin R.
Turtle, Lance
Wardale, Jahanara
Wooding, Dominic
Edwards, Thomas
Atienzar, Ana Cubas
Adams, Emily R.
Funding for this research was provided by:
Medical Research Council Doctoral Training Partnership
Wellcome Trust (205228/Z/16/Z)
U.S. Food and Drug Administration Medical Countermeasures Initiative Contract (75F40120C00085, 75F40120C00085)
National Institute for Health Research Health Protection Research Unit (HPRU) in Emerging and Zoonotic Infections (NIHR200907)
Article History
Received: 17 June 2022
Accepted: 27 January 2023
First Online: 23 February 2023
Declarations
:
: The NHS Research Ethics Committee (REC, UK) [REC reference:16/NW/0170] and the central Liverpool research ethics committee [Protocol Number: UoL001207] granted ethical approval for this work. The Integrated Research Application System (IRAS) Project ID is: 202413. All methods were carried out in accordance with the relevant guidelines and regulations and in line with our ethical approval. Participants were recruited onto an existing study (The Human Immune Responses to Acute Viral Infections study (AVIS), 16/NW/0160). All participants gave written informed consent.
: Not applicable.
: Emily Adams is Director of Epidemics and NTDs at GADx, UK, Sophie Owen is Clinical Affairs Officer at GADx, UK. GADx tests were not evaluated in this publication. There are no other competing interests to declare for the authors of this paper.